Sahar Salehi

Sahar Salehi

Assistant Professor | Docent
Visiting address: Widerströmska huset, Tomtebodavägen 18A, 17177 Stockholm
Postal address: K6 Kvinnors och barns hälsa, K6 NOGRH Falconer, 171 77 Stockholm

About me

  • I am a surgeon and Director of ovarian cancer surgery at the department of
    Pelvic Cancer, Karolinska University Hospital and Assistant Professor at
    Lehti Group, MTC, Karolinska Institutet.
    In the clinic I focus on advanced ovarian cancer surgery as well as
    robot-assisted surgery for cervical and endometrial cancer.
    My research is both clinical and translational with focus on the effect of
    surgical treatment on outcome in ovarian, cervical and endometrial cancer
    In the *Falconer group, KBH, * we examine oncologic outcomes related to
    surgical modality in cervical and endometrial cancer and surgical extent in
    advanced ovarian cancer.
    In the *Lehti group, MTC, * we examine how surgical treatment, the extent of
    surgery and local anesthetics affect mesothelial inflammation and tumor cell
    phenotype and functions in epithelial ovarian cancer (EOC). Moreover, the
    effects of identified molecular pathways on aggressive tumour properties such
    as invasion and chemotherapy resistance of EOC cells are tested in functional
    /ex vivo/ assays.
    1997-2003 Medical School at Karolinska Institutet
    2003-2004 Internship Sunderby Hospital, Luleå, Sweden
    2004-2009 Residency in Obstetrics and Gynecology, Stockholm South General
    Hospital, Stockholm, Sweden
    2009 Board Certified Gynecologist
    2010-2014 Subspecialist training in Gynecologic Oncology, Karolinska
    University Hospital
    2015 Certified Surgical Gynecologic Oncologist
    2018 PhD with thesis “Robot-assisted laparoscopy and sentinel node biopsy
    in high risk endometrial cancer”


  • Coordinating investigator (PI) *IPLA-OVCA
    trial* ( [1])
    Co-investigator (Co-PI) *RACC
    trial *( [2]),
    ( [3])
    Principal Investigator (PI) *STOOVCA *(Stockholm Ovarian Cancer Project)
    study group
    -------- *Five selected publications* ----------------------------------------
    Ultra-radical upfront surgery does not improve survival in women with
    advanced epithelial ovarian cancer
  • a natural experiment in a complete
    population. Gynecologic
    oncology 2020
    /Falconer H, Joneborg U, Krawiec K, Palsdottir K, Bottai M, *SALEHI S.*/
    Intraperitoneal ropivacaine reduces time interval to initiation of
    chemotherapy after surgery for advanced ovarian cancer: randomised controlled
    double-blind pilot study. British journal of anaesthesia 2020 124
  • 5 562-570 [5]
    /Hayden JM, Oras J, Block L, Thörn SE, Palmqvist C, * SALEHI S, *Nordstrom
    JL, Gupta A/
    Surgery performed later in the week is associated with failure to achieve
    complete radical surgical resection in advanced ovarian cancer. Acta
    oncologica (Stockholm, Sweden) 2020 59
  • 7 760-765 [6]
    /Palsdottir K, Joneborg U, Hasselgren E, Johansson H, *SALEHI S*/
    Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer
    (SHREC-trial)-the final step towards a paradigm shift in surgical staging.
    European journal of cancer 2019 116

  • 77-85 [7]
    /Persson J, *SALEHI S, *Bollino M, Lonnerfors C, Falconer H, Geppert B./
    Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic
    lymphadenectomy in women with high-risk endometrial cancer: A randomised
    controlled trial. European journal of cancer 2017 79
  • 81-89 [8]
    /*SALEHI S, *Åvall-Lundqvist E, Legerstam B, Carlson JW, Falconer H/


All other publications


  • Assistant Professor, Department of Women's and Children's Health, Karolinska Institutet, 2023-2024

Degrees and Education

  • Docent, Karolinska Institutet, 2022
  • Degree Of Doctor Of Philosophy, Department of Women's and Children's Health, Karolinska Institutet, 2018
  • University Medical Degree, Karolinska Institutet, 2003

News from KI

Events from KI